News & Perspective

May 10, 2021

May 10, 2021
Rows of ibuprofen tablets

Ibuprofen, other NSAIDs not tied to worse COVID illness, death

"We now have clear evidence that NSAIDs are safe to use in patients with COVID-19."

Jul 30, 2020

Jul 30, 2020

Stewardship / Resistance Scan for Jul 30, 2020

Antibiotics for MRSA bacteremia, endocarditis
Antibiotic prescribing for COVID-19
Pneumonia antibiotic approved in Europe

Feb 08, 2019

Feb 08, 2019

ASP Scan (Weekly) for Feb 08, 2019

Inadequate TB drug-susceptibility testing
New UK guidance on antibiotics for acute cough
FDA to review new Merck antibiotics
CARB-X novel antibiotic funding
Antibiotic prescribing intervention in China
Candida auris fungemia
Microbiology test use in Norway
CRP-guided therapy
Formulary restriction policy
New CARB-X funding

Sep 14, 2018

Sep 14, 2018

ASP Scan (Weekly) for Sep 14, 2018

UK-India diagnostics effort
Probiotics and antibiotic use in kids
Candida auris in New York
Resistance and rising temps
European One Health AMR plan
India bans combo drugs
MDR bacteria in farmed salmon
Resistant E coli in dogs
Essential-antibiotic price hike
Antibiotics and cough
Piperacillin-tazobactam trial results
Double antibiotic for pneumonia
C diff in food animals
Accessible antimicrobial resistance data

Jul 25, 2016

Jul 25, 2016

News Scan for Jul 25, 2016

Saudi MERS update
Ebola vaccine, viral shedding
New chikungunya cases

Oct 18, 2019

Oct 18, 2019
Ebola kids

WHO advisors extend Ebola emergency; European regulators conditionally approve vaccine

In other Ebola developments today, three newly confirmed cases were reported in the outbreak region.

Jun 04, 2010

Jun 04, 2010

BMJ, European group criticize WHO pandemic actions

(CIDRAP News) – An article published by the British Medical Journal says three scientists who helped frame World Health Organization (WHO) guidance on pandemic influenza preparedness had consulted for pharmaceutical companies that stood to profit from the WHO guidance and that the WHO did not disclose the scientists' industry ties.

Dec 22, 2008

Dec 22, 2008

EU panel supports innovative pandemic, seasonal flu vaccines

(CIDRAP News) – An H5N1 influenza vaccine made by Baxter International could become the first cell culture–based H5N1 influenza vaccine to be approved for marketing, following its endorsement by a committee of the European Medicines Agency (EMEA) last week.

Recommendations of the Committee for Medicinal Products for Human Use (CHMP) are usually followed by the EMEA within a few months.

Pages

by organization

Newsletter Sign-up

Get CIDRAP news and other free newsletters.

Sign up now»

OUR UNDERWRITERS

Unrestricted financial support provided by

Bentson Foundation Unorthodox Philanthropy logo and text 'Leading Underwriter'3M logoGilead 
Grant support for ASP provided by


bioMérieux

  Become an underwriter»